Physician profile
Brock Daughtry
NPI 1083234942
$2,830.11
in general payments reported to CMS, 2019-2025
9 companies · $992 in 2025
The $992 reported for 2025 was more than what 88% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,353 · 2023: $219 · 2024: $266 · 2025: $992.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $941 · Education: $537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $940.91 |
| Education | $536.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $1,361.97 | 2022-2024 | Phasix Mesh |
| Bard Peripheral Vascular, INC. | $599.24 | 2025 | Venovo |
| Medtronic, INC. | $190.76 | 2022-2025 | Endurant Iis, Rapidvac |
| Stryker Corporation | $174.55 | 2023 | Spy-Phi System |
| Penumbra, INC. | $157.55 | 2025 | Indigo System |
| Angiodynamics, INC. | $113.43 | 2025 | Nanoknife |
| Ethicon US, LLC | $95.37 | 2024 | Surgiflo Hemostatic Matrix, Stratafix |
| La Jolla Pharmaceutical Company | $94.72 | 2022 | |
| Kci USA, INC. | $42.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brock Daughtry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.